DanCann Pharmas vd Jeppe Krog Rasmussen presenterar i BioStocks studio

BioStock Investor Pitch: DanCann Pharma

Danish DanCann Pharma's goal is to improve the lives of patients through medical cannabis and cannabinoids. The company has signed an agreement with WEECO...
PolarCools VD Erik Andersson besökte BioStock Studio för att diskutera resultaten från en 5-årig klinisk studie med PolarCap publicerad i Journal of Neurotrauma

PolarCool boosted by 5-year clinical study results

Medtech company PolarCool has developed PolarCap, a medical device that actively cools down the brain in the acute phase of an injury to decrease...
Cyxone on the phase IIb sttudy

Cyxone on the phase IIb study

In September, biotech company Cyxone was approved by Polish authorities to start a phase IIb trial with drug candidate Rabeximod in rheumatoid arthritis. The...
NLSDays

NLSDays: Interviews with 10 interesting companies

On September 28-29, SwedenBIO held the Nordic Life Science Days partnering event in Malmö, the largest Nordic partnering and networking conference in the life...
Eir Ventures Sound Bioventures NLSDays2022

NLSDays: Sound Bioventures and Eir Ventures on the investment climate

One of NLSDays’ main aims is to connect investors and life science companies. Thus, several venture capital funds were present during the event in...
NLSDays

NLSDays: Navigare Ventures and ClexBio discussing deep tech

During Nordic Life Science Days 2022 in Malmö, several interesting panel discussions were arranged with prominent people in various fields. One of the discussions...
NLSDays

NLSDays: Stayble steps up partnering activities

Stayble's most important milestones going forward are to present study results from the phase IIb study with the drug candidate STA363 and then enter...
CLS vd Dan Mogren besöker BioStocks studio

BioStock Studio: CLS about the FDA clearance

In December last year, medtech Clinical Laserthermia Systems applied for FDA clearance for the second generation of the TRANBERG Thermal Therapy System with Thermoguide...
Anders Svensson, CFO på OssDsign

BioStock Investor Meeting: Interview with OssDsign

In connection with the BioStock Investor Meeting in Stockholm, BioStock's reporter was visited by Anders Svensson, CFO of OssDsign. Svensson told us more about...
Mia Lundblad, CEO Arcede Pharma

BioStock Investor Meeting: Interview with Arcede Pharma

Arcede Pharma, which just released its first quarterly report as a separately listed company, presented at the BioStock Investor Meeting in September. In connection...